Stay updated on Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added recruitment status note and new user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a revised Intervention/Treatment section; removed the older 'Intervention / Treatment' heading and the 'Revision: v3.5.5' note.
    Difference
    0.2%
    Check dated 2026-06-15T23:54:57.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5 instead of Revision: v3.5.4, indicating a small update to the page template or system, with no apparent changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-09T02:11:34.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The Locations section was updated to replace Kharkivs’ka Oblast’ with Kharkiv Oblast and to add a new entry for Kharkiv, Kharkiv Oblast, Ukraine, 61070; the former Kharkivs’ka Oblast’ entry (and its city/ZIP) was removed.
    Difference
    0.0%
    Check dated 2026-06-01T23:07:02.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision tag on the study page updated from v3.5.3 to v3.5.4. This reflects a new internal update to the page’s revision history.
    Difference
    0.0%
    Check dated 2026-05-18T13:38:29.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s revision label was updated from version v3.5.0 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-27T08:01:15.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-22T08:57:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab ± Lenvatinib in PD-L1+ NSCLC Clinical Trial page.